Laure Philippe

934 total citations
11 papers, 105 citations indexed

About

Laure Philippe is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Laure Philippe has authored 11 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Laure Philippe's work include Lymphoma Diagnosis and Treatment (5 papers), Cutaneous lymphoproliferative disorders research (3 papers) and CAR-T cell therapy research (2 papers). Laure Philippe is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Cutaneous lymphoproliferative disorders research (3 papers) and CAR-T cell therapy research (2 papers). Laure Philippe collaborates with scholars based in France and United States. Laure Philippe's co-authors include Sabeha Biichlé, Francis Bonnefoy, Philippe Saas, Francine Garnache‐Ottou, Fanny Angelot‐Delettre, Éric Deconinck, Elisabeth Macintyre, Sylvain Perruche, David Masson and Samuel Limat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Haematologica.

In The Last Decade

Laure Philippe

11 papers receiving 105 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laure Philippe France 4 53 50 33 32 21 11 105
V. Monsálvez Spain 5 16 0.3× 74 1.5× 25 0.8× 68 2.1× 15 0.7× 16 125
Andrea L. Salavaggione United States 7 24 0.5× 30 0.6× 10 0.3× 35 1.1× 17 0.8× 11 117
Nur-Taz Rahman United States 5 40 0.8× 42 0.8× 36 1.1× 17 0.5× 54 2.6× 8 135
Tim Malcolm United Kingdom 5 53 1.0× 11 0.2× 33 1.0× 74 2.3× 29 1.4× 5 126
Blandine Fabre France 6 26 0.5× 19 0.4× 18 0.5× 45 1.4× 11 0.5× 9 88
Stefano Pulini Italy 6 38 0.7× 93 1.9× 45 1.4× 78 2.4× 65 3.1× 24 192
Zhiming Li China 7 40 0.8× 11 0.2× 27 0.8× 65 2.0× 11 0.5× 12 87
Donald Chan United States 4 78 1.5× 89 1.8× 13 0.4× 8 0.3× 19 0.9× 7 175
Mark Wong United States 6 78 1.5× 37 0.7× 154 4.7× 28 0.9× 30 1.4× 15 188
Natasja Nielsen Viller United States 5 70 1.3× 30 0.6× 151 4.6× 24 0.8× 43 2.0× 11 187

Countries citing papers authored by Laure Philippe

Since Specialization
Citations

This map shows the geographic impact of Laure Philippe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laure Philippe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laure Philippe more than expected).

Fields of papers citing papers by Laure Philippe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laure Philippe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laure Philippe. The network helps show where Laure Philippe may publish in the future.

Co-authorship network of co-authors of Laure Philippe

This figure shows the co-authorship network connecting the top 25 collaborators of Laure Philippe. A scholar is included among the top collaborators of Laure Philippe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laure Philippe. Laure Philippe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Philippe, Laure, Maxime Fredon, Sabeha Biichlé, et al.. (2020). BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity. SHILAP Revista de lepidopterología. 2(1). 125–130. 1 indexed citations
3.
Jaccard, Arnaud, Jean‐François Benoist, Lucile Couronné, et al.. (2018). Monitoring Asparaginase Activity in 21 Patients with Extranodal NK/T-Cell Lymphoma Shows a Very High Proportion of Asparaginase Inactivation. Blood. 132(Supplement 1). 5351–5351. 1 indexed citations
4.
Philippe, Laure, Sabeha Biichlé, Sophie Perrin, et al.. (2017). Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm. Haematologica. 102(11). 1861–1868. 36 indexed citations
5.
Alcantara, Marion & Laure Philippe. (2017). Diffuse Large B-Cell Lymphoma. Hématologie. 23(S1). 27–34. 2 indexed citations
6.
Jaccard, Arnaud, Laure Philippe, Lucile Couronné, Jean‐François Benoist, & Olivier Hermine. (2017). NK/T‐CELL LYMPHOMA, THE FRENCH EXPERIENCE.. Hematological Oncology. 35(S2). 126–127. 3 indexed citations
7.
Masson, David, Anne Roggy, Christophe Roumier, et al.. (2016). LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis. Blood. 128(23). 2694–2707. 47 indexed citations
8.
Philippe, Laure, et al.. (2015). Fatal Thrombotic Thrombocytopenic Purpura in a Psoriasis Patient Treated with Ustekinumab and Methotrexate. Acta Dermato Venereologica. 95(4). 495–496. 4 indexed citations
9.
Philippe, Laure, et al.. (2014). Pseudo-microangiopathie : diagnostic à ne pas manquer !. La Revue de Médecine Interne. 35. A185–A186. 1 indexed citations
10.
Philippe, Laure, et al.. (1995). Small-cell carcinoma of the esophagus with regression after combination chemotherapy and radiation therapy.. PubMed. 46(1). 45–7. 2 indexed citations
11.
Philippe, Laure, et al.. (1972). [Clinical study of a current anorexigenic agent: T.D].. PubMed. 228(15). 291–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026